Advancements and challenges in esophageal carcinoma prognostic models: A comprehensive review and future directions

In this article, we comment on the article published by Yu et al. By employing LASSO regression and Cox proportional hazard models, the article identified nine significant variables affecting survival, including body mass index, Karnofsky performance status, and tumor-node-metastasis staging. We firmly concur with Yu et al regarding the vital significance of clinical prediction models (CPMs), including logistic regression and Cox regression for assessment in esophageal carcinoma (EC). However, the nomogram's limitations and the complexities of integrating genetic factors pose challenges. The integration of immunological data with advanced statistics offers new research directions. High-throughput sequencing and big data, facilitated by machine learning, have revolutionized cancer research but require substantial computational resources. The future of CPMs in EC depends on leveraging these technologies to improve predictive accuracy and clinical application, addressing the need for larger datasets, patient-reported outcomes, and regular updates for clinical relevance.